相关实验视频

Updated: May 24, 2025

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model

Published on: December 14, 2016

在心血管感染中早期纤维素生物膜的发展

Safae Oukrich¹, Jane Hong¹, Mariël Leon-Grooters¹

¹Biomedical Engineering, Department of Cardiology, Cardiovascular Institute, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.

|March 4, 2025

概括

黄金葡萄球菌使用凝固酶形成纤维素生物膜,对于心血管感染至关重要. 这项研究揭示了S. aureus心血管生物膜中早期纤维素形成机制.

科学领域:

微生物学微生物学
心血管医学心血管医学
生物化学生物化学

背景情况:

金黄色葡萄球菌是心血管感染的主要原因.
黄金菌的凝血酶生产促进了纤维素到纤维素的转化,有助于生物膜的形成.
在S. aureus心血管生物膜中纤维素形成的早期阶段尚不清楚.

研究的目的:

为了研究由黄金葡萄球菌引起的心血管生物膜的早期发展.
了解凝固酶在纤维素基生物膜形成中的作用.
在各种条件下分析细菌生长,代谢活动和纤维素原利用.

主要方法:

在不同介质 (TSB,IMDM,人体血) 中培养临床分离物 (S. aureus,S. lugdunensis,S. aureus Δcoa),有或没有猪心脏.
在24小时内测量细菌生长,代谢活动和纤维素素利用率.
时间延迟共聚焦显微镜用于可视化生物膜发育和纤维素网络结构.

主要成果:

与S. lugdunensis和S. aureus Δcoa.相比,S. aureus在TSB和人体血中显示出增强的增长.
峰值代谢活性在TSB中最高,在人体血中最低,其变化受到猪门的影响.
聚焦显微镜证实了基于纤维素的生物膜发育,仅在产生凝固酶的黄金色菌株中,在人体血中,最初的纤维素链在3小时内形成.

结论:

纤维素的形成,由黄金凝酶介导,是心血管生物膜发育的关键早期事件.
实验条件显著影响细菌的行为和生物膜的形成.
这项研究为S. aureus心血管感染的发病过程提供了关键的见解.

关键词:

生物膜的发展发展.心血管感染的心血管感染.凝结剂凝结剂是指凝结的纤维素纤维素是一种纤维素.纤维素原蛋白是一种纤维素.黄金葡萄球菌黄金葡萄球菌

更多相关视频

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Bile Salt-induced Biofilm Formation in Enteric Pathogens: Techniques for Identification and Quantification

Bile Salt-induced Biofilm Formation in Enteric Pathogens: Techniques for Identification and Quantification

Published on: May 6, 2018

相关概念视频

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...